CTRI/2022/01/039845已完成未知
A prospective, open-label, comparative study of non-invasive diagnostic test platform TruCov based three products with invasive oral/nasal swab RTPCR method for the diagnosis of Covid-19 infection
euome Technologies Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects aged 05-75 years of age and of either sex
- •2.Subjects who are willing to give consent to the study
- •3.Mild to moderate COVID-19 clinical symptoms and not confirmed by the any current recommended COVID-19 test
- •4.Can take oral medicines
- •5.Subject willing to abide by and comply with the study protocol
排除标准
- •1.Volunteers who are in ICU or unconscious or unable to give breath samples.
- •2.History of having received or participated in any other similar clinical trial in the last 24 hrs or currently ongoing.
- •3.Any condition that in the opinion of the investigator does not justify the patientââ?¬•s inclusion for the study
研究者
相似试验
已完成
不适用
Prospective, open-label, comparative study on the efficacy of triple (aprepitant + granisetron 3 mg + dexamethasone) versus double (palonosetron 0.75 mg + dexamethasone) combination therapy for nausea and vomiting during moderately emetogenic chemotherapy containing carboplatin: CAP StudyMalignancy treated with chemotherapy containing carboplatinJPRN-UMIN000010186Kyushu Medical Center Clinical Research Institute200
已完成
Unknown
A prospective study on the effects and mechanism of VR(virtual reality) on chronic neuropathic paiJPRN-UMIN000052917Juntendo University of Medicine5
招募中
Unknown
A study on effects of ticagrelor and prasugrel on inflammatory markers, in diabetic patients undergoing percutaneous coronary interventioCTRI/2023/06/054193Dr Ankita Panigrahy
已完成
Unknown
A Prospective, randomized, comparative study of a soft tissue matrix covering bone-level implants: Influence on tissue thickening and marginal bone loss.Peri-implant HealthDRKS00033290niversität Zürich40
尚未招募
不适用
preventive efficacy and safety of Asmidine Spray, metered-dose inhaler in patients with partially controlled asthma.CTRI/2021/06/034142VITROBIO SAS